Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial

被引：0
|
作者：
Hasan Mirzazadeh [1 ]
Younes Ghaeminia [2 ]
Amin Mohamad Niaei [3 ]
Mohammadsadegh Kamran [4 ]
Leila Razeghian Jahromi [1 ]
Reza Moshfeghinia [1 ]
机构：
[1] Shiraz University of Medical Sciences,Research Center for Psychiatry and Behavior Science
[2] Shiraz University of Medical Sciences,School of Medicine
[3] Lorestan University of Medical Sciences,Student Research Committee
[4] Fasa University of Medical Sciences,Student Research Committee
[5] Shiraz University of Medical Science,Student’s research committee
[6] Shiraz University of Medical Sciences,Substance Abuse Research Center
来源：
BMC Psychiatry | / 25卷 / 1期
关键词：
Memantine; Escitalopram; Obsessive-Compulsive Disorder (OCD); Executive function; Augmentation therapy;
D O I：
10.1186/s12888-025-06856-7
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials
    Dold, Markus
    Aigner, Martin
    Lanzenberger, Rupert
    Kasper, Siegfried
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (03) : 557 - 574
  • [22] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
  • [23] A randomized, double-blind, placebo-controlled study of escitalopram in patients with social anxiety disorder in Japan
    Asakura, Satoshi
    Hayano, Taiji
    Hagino, Atsushi
    Koyama, Tsukasa
    CURRENT MEDICAL RESEARCH AND OPINION, 2016, 32 (04) : 749 - 757
  • [24] Memantine in Systemic Lupus Erythematosus: A Randomized, Double-Blind Placebo-Controlled Trial
    Petri, Michelle
    Naqibuddin, Mohammad
    Sampedro, Margaret
    Omdal, Roald
    Carson, Kathryn A.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 194 - 202
  • [25] Does Pregnenolone Enhance Exposure Therapy in Obsessive-Compulsive Disorder? - A Pilot, Interim Report of a Randomized, Placebo-Controlled, Double-Blind Study
    Kellner, M.
    Nowack, S.
    Wortmann, V.
    Yassouridis, A.
    Wiedemann, K.
    PHARMACOPSYCHIATRY, 2016, 49 (02) : 79 - 81
  • [26] Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study
    Hassanpour, Fatemeh
    Zarghami, Mehran
    Mouodi, Sussan
    Moosazadeh, Mahmood
    Barzegar, Fatemeh
    Bagheri, Maedeh
    Hendouei, Narjes
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 634 - 638
  • [27] Effects of memantine added to risperidone on the symptoms of schizophrenia: A randomized double-blind, placebo-controlled clinical trial
    Mazinani, Robabeh
    Nejati, Somayeh
    Khodaei, Mohammadreza
    PSYCHIATRY RESEARCH, 2017, 247 : 291 - 295
  • [28] Memantine in the Treatment of Executive Function Deficits in Adults With ADHD: A Pilot-Randomized Double-Blind Controlled Clinical Trial
    Biederman, Joseph
    Fried, Ronna
    Tarko, Laura
    Surman, Craig
    Spencer, Thomas
    Pope, Amanda
    Grossman, Rebecca
    McDermott, Katie
    Woodworth, K. Yvonne
    Faraone, Stephen V.
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (04) : 343 - 352
  • [29] Daily Oral Memantine Attenuated the Severity of Borderline Personality Disorder Symptoms: A Double-Blind Placebo-Controlled, Randomized Clinical Trial
    Mohammadsadeghi, Homa
    Soleimannejad, Maryam
    Ramazi, Samira
    Shalbafan, Mohammadreza
    Ardebili, Mehrdad Eftekhar
    Vahabzadeh, Gelareh
    Ahmadirad, Nooshin
    Karimzadeh, Fariba
    IRANIAN JOURNAL OF PSYCHIATRY AND BEHAVIORAL SCIENCES, 2023, 17 (02)
  • [30] An 8-week, Randomized, Double-blind, Placebo-controlled Trial of Adjunctive Ziprasidone in Patients with Major Depressive Disorder Receiving Treatment with Escitalopram
    Papakostas, George
    Swee, Michaela B.
    Baer, Lee
    Shelton, Richard C.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S344 - S345
12345